BCIQ Profiles

Company Profile Report
0525 Provention
BioCentury & Getty Images


With clearer path to approval, Provention’s teplizumab poised to break new ground in Type I diabetes 

May 26, 2021 | 1:42 AM GMT

FDA briefing documents for teplizumab helped shares of Provention recover lost

Read the full 379 word article

How to gain access

Continue reading with a
two-week free trial.